Abstract: A physiologic data acquisition system includes an analog input, a sigma-delta front end signal conditioning circuit adapted to subtract out DC and low frequency interfering signals from and amplify the analog input before analog to digital conversion. The system can be programmed to acquire a selected physiologic signal, e.g., a physiologic signal characteristic of or originating from a particular biological tissue. The physiologic data acquisition system may include a network interface modulating a plurality of subcarriers with respective portions of an acquired physiologic signal. A receiver coupled to the network interface can receive physiologic data from, and send control signals and provide power to the physiologic data acquisition system over a single pair of wires. The network interface can modulate an RF carrier with the plurality of modulated subcarriers and transmit the resulting signal to the receiver across a wireless network.

Abstract: According to one aspect of the present invention there is provided a manually operated post handling assembly including a main body, a post driver that is integral with or connected to the main body and a post extractor being adapted to move between a deployed position and a stowed position within the main body.

Abstract: A semiconductor patch antenna for microwave radiation having a wide pin-junction or pn-junction with the depletion region or embodiments having a separating buried oxide (SiO2) layer between p- and n-doped regions as the natural resonator volume. Embodiments that do not include a metal ground plane and/or a metal patch are disclosed.

Abstract: The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

Abstract: The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.

Abstract: The present application relates to novel compounds, methods and formulations useful for the oral delivery of a glucagon like peptide-1 compound or a melanocortin 4 receptor agonist peptide.

Abstract: According to one aspect of the present invention there is provided a manually operated post handling assembly including: a main body; a post drive means integral with or connected to the main body; and a post extraction means including a post grip assembly operatively connected to the main body, the post extraction means being adapted to move between a deployed position and a stowed position.

Abstract: A method, apparatus, and program storage device for integrating and implementing rule-based, heuristic, wellbore key performance rate of penetration indicators advising drilling operations personnel based on the situational awareness of trended earth properties and real time wellbore sensor data, is disclosed.

Abstract: The invention provides a temporary fence including a barrier assembly comprising one or more posts (103), one or more fence panels (101) mounted thereon and one or more anchors (120) to anchor the posts consisting of two elements (112) that have a cleft (109) between them when assembled, there are also anchors (913) having a first post mounting (921) for the post of a first fence and a spaced apart second mounting (922) for a post of a second fence. Also there is a mounting bracket mounted on a post (916) of a first fence for receiving an upper portion of a second fence (920) an with attachment means at its distal end (924) from the first post such that when assembled the upper attached portion of the second fence is disposed generally vertically above a base portion of the second fence.

Abstract: The present invention relates to novel compounds, methods, and formulations useful for the oral delivery of a GLP-1 compound or an MC4 agonist peptide.

Abstract: A calibratable analog-to-digital converter system with a split analog-to-digital converter architecture including N Analog-to-Digital Converters (ADCs) each configured to convert the same analog input signal into a digital signal. Calibration logic is responsive to the digital signals output by the N ADCs and is configured to calibrate each of the ADCs based on the digital signals output by each ADC.

Abstract: A programmable error amplifier (PEA) that may be used as part of a voltage regulation subsystem to control the output of a digitally programmable voltage source is disclosed. According to various embodiments, the PEA comprises an amplification circuit, an analog voltage sampling circuit and a digital reference voltage sampling circuit. The amplification circuit may employ a negative feedback configuration, and include an amplifier and a plurality of feedback capacitors. The analog voltage sampling circuit is responsive to an analog input voltage (such as the output of the programmable voltage source) and is coupled to the amplification circuit. During a first operational phase (the sampling phase), the analog voltage sampling circuit stores a charge dependent upon the analog input voltage, and during a second operational phase (the conversion phase), the analog voltage sampling circuit transfers the charge to the feedback capacitors of the amplification circuit.

Abstract: A calibratable analog-to-digital converter system with a split analog-to-digital converter architecture including N Analog-to-Digital Converters (ADCs) each configured to convert the same analog input signal into a digital signal. Calibration logic is responsive to the digital signals output by the N ADCs and is configured to calibrate each of the ADCs based on the digital signals output by each ADC.

Abstract: A physiologic data acquisition system includes an analog input, a sigma-delta front end signal conditioning circuit adapted to subtract out DC and low frequency interfering signals from and amplify the analog input before analog to digital conversion. The system can be programmed to acquire a selected physiologic signal, e.g., a physiologic signal characteristic of or originating from a particular biological tissue. The physiologic data acquisition system may include a network interface modulating a plurality of subcarriers with respective portions of an acquired physiologic signal. A receiver coupled to the network interface can receive physiologic data from, and send control signals and provide power to the physiologic data acquisition system over a single pair of wires. The network interface can modulate an RF carrier with the plurality of modulated subcarriers and transmit the resulting signal to the receiver across a wireless network.

Abstract: A programmable error amplifier (PEA) that may be used as part of a voltage regulation subsystem to control the output of a digitally programmable voltage source is disclosed. According to various embodiments, the PEA comprises an amplification circuit, an analog voltage sampling circuit and a digital reference voltage sampling circuit. The amplification circuit may employ a negative feedback configuration, and include an amplifier and a plurality of feedback capacitors. The analog voltage sampling circuit is responsive to an analog input voltage (such as the output of the programmable voltage source) and is coupled to the amplification circuit. During a first operational phase (the sampling phase), the analog voltage sampling circuit stores a charge dependent upon the analog input voltage, and during a second operational phase (the conversion phase), the analog voltage sampling circuit transfers the charge to the feedback capacitors of the amplification circuit.

Abstract: A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.

Abstract: The present invention is directed to chemical processes for preparing 2-aryl-6-hydroxy-3-[4-(2-aminoethoxy)benzoyl]benzo[b]-thiophenes. The present invention is also directed to crystalline solvates and a non-solvated crystalline form of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]thiophene hydrochloride, as well as processes for their preparation.